Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: Induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1156-1168

  Wigginton, J M ^a   Park, J W ^a   Gruys, M E ^a   Young, H A ^a   Jorcyk, C L ^a   Back, T C ^a   Brunda, M J ^a   Strieter, R M ^a   Ward, J ^a   Green, J E ^a   Wiltrout, R H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; MONOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER REGRESSION; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; IMMUNE SYSTEM; MEMORY CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0035863738     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1156     Document Type: Article

References (67)

1. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
2. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
3. Immunoregulation by interleukin-12
4. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
5. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production
6. Antitumor activity of interleukin-12 in preclinical models
7. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: Differential use of Janus family tyrosine kinases by IL-2 and IL-12
8. IL-12 receptor. II. Distribution and regulation of receptor expression
9. Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-I clone
10. Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro
11. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
12. + T lymphocytes and NK ceLls
13. + T lymphocytes
14. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells
15. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: Implications for the antitumor activity of interleukin 12 and/or interleukin 2
16. Administration of interleukin 12 and pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma
17. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(I) simian virus 40 large tumor antigen fusion gene
18. Biological activity f recombinant human interleukin-2 produced in Escherichia coli
19. Site-specific mutagenesis of the human interleukin-2 gene: Structure-function analysis of the cysteine residues
20. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma
21. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12
22. Interleukin 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma
23. Cancer immunotherapy of established tumors with IL-12: Effective delivery by genetically engineered fibroblasts
24. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells
25. Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system
26. Interleukin-12: Murine models of a potent antitumor agent
27. γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins
28. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines
29. Expression of IP-10, a lipopolysaccharide- and interferon-γ-inducible protein, in murine mesangial cells in culture
30. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo
31. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-γ
32. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi
33. Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils
34. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
35. Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis
36. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
37. Inhibition of angiogenesis in vivo by interleukin 12
38. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
39. Interleukin-12 (IL-12) modulates cytokine gene expression in human renal cell carcinoma (RCC): In vitro and in vivo studies
40. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
41. Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
42. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells
43. Expression of the Fas ligand in cells of T cell lineage
44. Fas expression and function in normal and malignant breast cell lines
45. Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells
46. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: Induction and modulation of sensitivity by cytokines
47. Anti Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
48. A role for CD95 ligand in preventing graft rejection
49. Fas ligand-induced apoptosis as a mechanism of immune privilege
50. Fas-mediated cytotoxicity by freshly isolated natural killer cells
51. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
52. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
53. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity
54. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity
55. Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice
56. Lymphocyte apoptosis induced by CD95(APO-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion?
57. Melanoma cell expression of Fas(Apo-1/CD95.) ligand: Implications for tumor immune escape
58. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
59. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
60. Local Fas/APG-1 (CD95) ligand-mediated tumor cell killing in vivo
61. Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas
62. Monoclonal antibody-mediated tumor regression by induction of apoptosis
63. Fas/APO-I(CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells
64. Interferon-γ inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells
65. Lethal effect of the anti-Fas antibody in mice
66. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice
67. Estrogen promotes increased mammary tumor development in C3(1)/SV40 Tag transgenic mice: Paradoxical loss of ERα expression during tumor development